Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Prabha Viswanathan"'
Autor:
Shanthi Prabha Viswanathan, Gopika Vijayakumar Njazhakunnathu, Sreekanth Prakasan Neelamury, Babu Padmakumar, Thomas Paili Ambatt
Publikováno v:
Environmental Management.
Autor:
Shanthi Prabha Viswanathan, Gopika Vijayakumar Njazhakunnathu, Sreekanth Prakasan Neelamury, Babu Padmakumar, Thomas Paili Ambatt
Publikováno v:
Biomass Conversion and Biorefinery.
Autor:
Prabha Viswanathan, Kimberly A Struble, Mario R Sampson, Vikram Arya, Sarita D. Boyd, Adam Sherwat
Publikováno v:
AIDS. 33:1089-1093
Product labels for cobicistat with atazanavir or darunavir, and for elvitegravir/cobicistat/emtricitabine/tenofovir (alafenamide or disoproxil fumarate) were recently updated to state that these products are not recommended for initiation during preg
Publikováno v:
Clinical Pharmacology & Therapeutics. 104:785-787
The article by Adkison et al. described sorbitol effects on lamivudine exposures. The results indicate a plausible mechanism for lower lamivudine exposures in pediatric patients receiving the solution formulation with concomitant medications containi
Publikováno v:
International Journal of Imaging Systems & Technology. Sep2015, Vol. 25 Issue 3, p226-244. 19p.
Autor:
Sreekanth Prakasan Neelamury, Shanthi Prabha Viswanathan, Ambatt PailiThomas, Babu Padmakumar
Publikováno v:
Climate Change and Environmental Sustainability. 8:38
Autor:
LaRee Tracy, Jeffrey S. Murray, Prabha Viswanathan, Sarita D. Boyd, Patrick R. Harrington, Adam Sherwat, Takashi E. Komatsu
Publikováno v:
Clinical drug investigation. 37(4)
Elbasvir/grazoprevir demonstrated high sustained virologic response rates 12 weeks after the end of treatment (SVR12) across five clinical trials in subjects infected with chronic hepatitis C virus (HCV) genotype 1, including those with advanced chro
Autor:
Prabha Viswanathan, Wendy Carter, LaRee Tracy, Yodit Belew, Mario R Sampson, Sung Rhee, Tanvir Bell, Islam R. Younis, Melisse Baylor
Publikováno v:
Open Forum Infectious Diseases
Background Elvitegravir (EVG)/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) is approved for treatment of HIV-1 in children weighing ≥25 kg based on a Gilead sponsored study of safety, pharmacokinetics (PK), and antiviral activity among
Publikováno v:
Journal of Circuits, Systems and Computers. 14:1173-1182
Dynamic power management is a technique to reduce power consumption of electronic systems by selectively shutting down idle components. In this paper, an intelligent approach is presented based on reinforcement learning to predict the best policy amo
Publikováno v:
Journal of Circuits, Systems and Computers. 14:987-996
Power is increasingly becoming a design constraint for embedded systems. Dynamic Power Management algorithms enable optimal utilization of hardware at runtime. The present work attempts to arrive at an optimal policy to reduce the energy consumption